During September of last year, drug regulators said that the diabetes medicine, Avandia, will no longer be widely available. However, this drug is still available to individuals who previously took Avandia, as well as those who tried other diabetes medications that proved no help.
The reason for limiting Avandia from the market is its link to heart risk. According to a New York Times article, "one study estimated that from 1999 to 2009, more than 47,000 people taking Avandia needlessly suffered a heart attack, stroke, or heart failure, or died."
The reason for limiting Avandia from the market is its link to heart risk. According to a New York Times article, "one study estimated that from 1999 to 2009, more than 47,000 people taking Avandia needlessly suffered a heart attack, stroke, or heart failure, or died."
No comments:
Post a Comment